Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Also in the market are Tirzepatide products like Mounjaro / Zepbound, offering similar benefits by acting on both GLP-1 and GIP receptors
Stay Active with Personalized Fitness Guidance Exercise is crucial for maintaining weight loss
Choose Safety Profile Adverse reactions reported in 3% of Wegovy 2.4 mg injection-treated adolescent patients aged 12 years and older with obesity and more frequently than with placebo 1 Gastrointestinal disorders were the most frequent adverse events with Wegovy ( 62% vs 42% with placebo) 2.3% of patients treated with Wegovy vs 1.5% of patients who received placebo discontinued treatment as a result of gastrointestinal adverse events 6 Mean increases in resting heart rate of 1.2 beats per minute from baseline were observed with patients taking Wegovy vs a decrease of 2.3 beats per minute with placebo 6 Adverse reactions with Wegovy treatment in pediatric patients aged 12 years and older were similar to those reported in adults
Seeking Help for Opioid Addiction Today GLP-1 drugs arent yet an approved or available treatment for opioid addiction
Semaglutide injections, a glucagon-like peptide-1 (GLP-1) receptor agonist, are an effective tool for managing weight by regulating appetite and glucose metabolism
